Current Discoveries and Management of Psammomatous Melanotic Schwannoma
Journal Title: Journal of Cancer and Tumor International - Year 2016, Vol 3, Issue 3
Abstract
Psammomatous melanotic schwannoma is a rare form of schwannoma that is distinct in terms of presentation, location, and nature compared to other types. This tumor is highly associated with Carney complex, but has also been seen in the neurofibromatosis syndromes. Although discovered over 80 years ago, official management guidelines have not been established. The following review comprises the current understanding of this rare tumor including genetic associations, presentation, imaging, pathology, prognosis, and management.
Authors and Affiliations
Juan A. Siordia, Todd R. Golden
The Relationship between Single Nucleotide Polymorphisms of Gene XRCC1 and Toxicity Induced Radiation in Patients with Head and Neck Cancer
Aims: The head and neck cancer is one of the most common types and their treatment brings complications such as dermatitis, mucositis and dysphagia. Studies of genetic variations of patients are those that enable the ide...
ABL1 is Overexpressed and Activated in Hepatocellular Carcinoma
Background and Aims: ABL1 is a non-receptor tyrosine kinase of the Abelson (Abl) family, which plays an important role in cell growth, survival, invasiveness, adhesion, and migration. Despite the well-known role of BCR-A...
Sarcomatoid Carcinoma (Carcinosarcoma) of the Prostate Gland: A Review of the Literature
Background: Adenocarcinomas of the prostate gland are commonly encountered globally but other uncommon variants of carcinoma of the prostate are sporadically encountered including primary sarcomatoid carcinoma of the pro...
Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review
The article relates in general to intralipid and its use in cancer therapy. Specifically, it relates to the combined intralipid-urotherapy for treating cancer, and methods of such treatment. Cancer cells release various...
Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Aims: Advanced Hepatocellular carcinoma (HCC) is a major health problem with limited treatment options. The Sorafenib monothearpy is the only efficacious systemic treatment agent showing a survival benefit in these patie...